CELG News 168.31 06/20/2014 04:32:59 Celgene Corp (CELG)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Celgene Corp (CELG) 168.31 $CELG

'Fast Money' Recap: Late-Day Rally, Another Record High
at The Street - 32 mins ago
The trading panel looked at gold and oil as the S&P hit another record high.

Jim Cramer's 'Mad Money' Recap: Management Matters, Not the Fed
at The Street - Thu Jun 19, 6:57PM CDT
People obsessed with the Fed have kept you out of the market, Cramer said, and the Fed's bond buyback tapering is simply not having an impact.

Final Glance: Biotechnology companies
AP - Thu Jun 19, 5:03PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading:

Celgene Set to Possibly Pullback After Yesterday's Rally of 4.49%
Comtex SmarTrend(R) - Thu Jun 19, 3:41PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $163.21 to a high of $168.49. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $162.00 on volume of 4.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

After Yesterday's Rally of 4.49% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Jun 19, 3:40PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $163.21 to a high of $168.49. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $162.00 on volume of 4.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Stocks On Track To End Win Streak; Oracle Reports After Close
at Investor's Business Daily - Thu Jun 19, 1:59PM CDT
Stocks were off their session lows in late trading Thursday but were still poised to snap a four-session win streak. The Nasdaq was off by 0.3%, while the S&P 500 slipped 0.1%. They had been down as much as 0.5% and 0.2%, respectively. The Dow Jones...

Midday Glance: Biotechnology companies
AP - Thu Jun 19, 12:18PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:

Today's Top Performers In Health Care
at The Street - Thu Jun 19, 12:04PM CDT
TheStreet highlights 3 stocks pushing the health care sector higher today.

Early Glance: Biotechnology companies
AP - Thu Jun 19, 9:57AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 10 a.m.:

Jim Cramer's Mad Dash: Starbucks and Celgene Have Upside
at The Street - Thu Jun 19, 9:48AM CDT
TheStreet's Jim Cramer, co-manager of the Action Alerts PLUS portfolio, is taking a look at shares of Celgene and Starbucks, both of which have upside potential and caught some bullish commentary from analysts.

Stocks Stage Tightly Mixed Open; Kroger, Celgene, BitAuto Gain
at Investor's Business Daily - Thu Jun 19, 9:32AM CDT
Stocks edged into a tightly mixed formation in early trading Thursday, as mixed economic news provided no clear direction. The Nasdaq, Dow Jones industrial average and the S&P 500 were all essentially flat. The Russell 2000 inched up to a fractional...

Today's Top Health Care Stocks to Watch: Celgene and Rite Aid
George Budwell, The Motley Fool - Motley Fool - Thu Jun 19, 8:06AM CDT
Let's take a look at today's top stories in biotech and health care. Keep an eye out for Celgene and Rite Aid   Celgene shares move higher after split is announced Celgene shareholders approved a two for one stock split yesterday at the...

Celgene Stockholders Approve Two-for-One Stock Split
Business Wire - Thu Jun 19, 7:30AM CDT
Celgene Corporation (NASDAQ:CELG) today announced that its stockholders approved a two-for-one stock split and an increase from 575 million to 1,150 million in the number of authorized shares of the Company's common stock at the Company's Annual Meeting of Stockholders on June 18, 2014. Based on the total number of shares of common stock outstanding as of June 17, 2014, the stock split will increase the total number of shares of common stock outstanding from approximately 399 million to approximately 798 million.

Better Stock Today Challenge: Celgene vs. Facebook
David Williamson and Jamal Carnette, The Motley Fool - Motley Fool - Wed Jun 18, 3:32PM CDT
In the spirit of World Cup competition, we're holding our own tournament in search of the Better Stock Today. We're pitting 32 companies against each other and you, the reader, will determine the winner. Celgene  takes on  Facebook  for this first...

Biotech Stock Roundup: HCV Back in Focus - Idenix, Achillion Soar - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Jun 18, 9:33AM CDT
It was about hepatitis C cirus (HCV) treatments and companies last week with the Merck-Idenix acquisition announcement grabbing eyeballs.

'Mad Money' Lightning Round: Sell, Sell, Sell Exxon Mobil
at The Street - Wed Jun 18, 5:00AM CDT
Cramer thinks Westlake Chemical is a winner but he's staying away from Smith & Wesson.

Jim Cramer's 'Mad Money' Recap: Don't Bet Against This Market
at The Street - Tue Jun 17, 7:31PM CDT
The market reacted correctly to the continued tensions in Iraq and the effect on oil, Cramer said.

How Much Does This Failure Hurt Celgene?
Michael Douglass and David Williamson, The Motley Fool - Motley Fool - Tue Jun 17, 4:30PM CDT
Celgene 's Vidaza, which began facing U.S. generic competition in September of 2013, just can't seem to catch a break. First there was the generic competition -- which dropped sales by 27% year-over-year last quarter to $148 million. And more...

Celgene's Pomalyst Data at European Hematology Association Shows Promise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 17, 12:40PM CDT
Celgene (CELG) presented data from a retrospective analysis of a phase III study on Pomalyst in the MM indication.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 657

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 552

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 248

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 419

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 375

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 488

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 348

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 100

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading

Top 5 Most Recently Viewed Articles

Orchestra BioMed Achieves Major Milestones in Q2 Progress

Updated Category News Views 147

Orchestra BioMed Reports Strong Financial Performance Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO), a pioneering biomedical innovation firm, recently announced notable financial results for the second quarter of 2025. The company has made significant strides in securing over $111 million in proceeds from strategic transactions and concurrent public and private equity...

Continue Reading
Euhomy Unveils Innovative Portable Ice Makers at CES 2026

Updated Category News Views 225

Exciting Innovations from Euhomy at CES 2026 CES 2026 is the stage where Euhomy introduces four remarkable portable ice makers. Each model is thoughtfully crafted to suit various occasions, whether it’s a lively outdoor BBQ, an elegant cocktail gathering, or a quiet evening relaxing at home. The Euhomy products are designed to elevate every drink with fresh and...

Continue Reading
American Regent Recalls Papaverine Injection Nationwide

Updated Category News Views 52

When Glass and Medicine Don't Mix Walking a tightrope in pharmaceutical production is no small feat, but American Regent, Inc. just stepped off the safety line with a recall of their Papaverine Hydrochloride Injection. We're talking visible glass and paraformaldehyde floating in those vials like unwelcome party guests. That's a gamble nobody wants to take, especially when...

Continue Reading
AIxCrypto Strengthens Legal Team with Andrew Grossman Appointment

Updated Category News Views 109

AIxCrypto Appoints Andrew Grossman as Head of Legal A recent transformation is underway at AIxCrypto Inc. This innovative company, recognized on the Nasdaq under the ticker AIXC, has elevated its legal operations with the appointment of Andrew Grossman as Head of Legal. Grossman’s role will encompass pivotal responsibilities in legal, compliance, and governance...

Continue Reading
Innovative Urine-Absorbing Accessory Developed for Men

Updated Category News Views 178

Revolutionary Invention to Combat Urine Leaks An inventor from Maryland has created a new accessory, LAST DROP, specifically designed to absorb urine leaks. The inspiration stemmed from personal experiences with prostate cancer, highlighting the need for improved comfort and hygiene for men dealing with this sensitive issue. Features and Benefits of LAST DROP LAST DROP...

Continue Reading